Jiangsu Hengrui Pharmaceuticals Co.,Ltd (SHA:600276)

China flag China · Delayed Price · Currency is CNY
48.67
-1.37 (-2.74%)
Jun 26, 2026, 3:00 PM CST
-8.08%
Market Cap 321.54B
Revenue (ttm) 32.56B
Net Income (ttm) 8.12B
Shares Out 6.62B
EPS (ttm) 1.22
PE Ratio 39.87
Forward PE 34.82
Dividend 0.20 (0.40%)
Ex-Dividend Date May 27, 2026
Volume 74,961,679
Average Volume 83,526,424
Open 50.46
Previous Close 50.04
Day's Range 48.65 - 50.73
52-Week Range 45.26 - 74.04
Beta 0.13
RSI 47.10
Earnings Date Aug 20, 2026

About SHA:600276

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. The company develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China. [Read more]

Sector Healthcare
Founded 1970
Employees 20,602
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600276
Full Company Profile

Financial Performance

In 2025, SHA:600276's revenue was 31.63 billion, an increase of 13.02% compared to the previous year's 27.98 billion. Earnings were 7.71 billion, an increase of 21.69%.

Financial Statements

Analyst Forecast

According to 20 analysts, the average rating for 600276 stock is "Strong Buy." The 12-month stock price target is ¥81.14, which is an increase of 66.72% from the latest price.

Price Target
¥81.14
(66.72% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Quarterly report: Q1 2026

Jiangsu Hengrui Pharmaceuticals Co.,Ltd has published its Q1 2026 quarterly earnings report on April 22, 2026.

2 months ago - Filings

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Annual report: H2 2025

Jiangsu Hengrui Pharmaceuticals Co.,Ltd has published its H2 2025 annual report on March 25, 2026.

3 months ago - Filings

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Earnings release: H2 2025

Jiangsu Hengrui Pharmaceuticals Co.,Ltd released its H2 2025 earnings on March 25, 2026, summarizing the period's financial results.

3 months ago - Filings

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Quarterly report: Q3 2025

Jiangsu Hengrui Pharmaceuticals Co.,Ltd has published its Q3 2025 quarterly earnings report on October 27, 2025.

8 months ago - Filings

Jiangsu Hengrui Pharmaceuticals Co.,Ltd Quarterly report: H1 2025

Jiangsu Hengrui Pharmaceuticals Co.,Ltd has published its H1 2025 quarterly earnings report on August 20, 2025.

11 months ago - Filings